Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL7942535 | 1.00 | — | — | |
| Iodide SCHEMBL176899 | 1.00 | — | — | |
| Iodide SCHEMBL28299602 | 1.00 | — | — | |
| Iodide SCHEMBL3374494 | 1.00 | CA4 (0.50) | — | |
| Iodide SCHEMBL31472568 | 1.00 | — | — | |
| Iodide SCHEMBL27902781 | 1.00 | — | — | |
| Iodide SCHEMBL28105529 | 1.00 | — | — | |
| Iodide SCHEMBL27569 | 1.00 | — | — | |
| Iodide SCHEMBL69895 | 1.00 | — | — | |
| Iodide SCHEMBL9278729 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116845221-A | Negative electrode material and preparation method thereof, negative electrode, lithium battery and preparation method thereof | 合肥国轩高科动力能源有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-115611822-B | Preparation method of isaconazole intermediate | 四川澄华生物科技有限公司 | 2023-09-19 | — | — | CN | claimed |
| US-10384942-B2 | Halogen doped phosphorus nanoparticles and manufacturing method thereof | NATIONAL TSING HUA UNIVERSITY (TW) | 2019-08-20 | — | — | US | claimed |
| CN-119601527-A | Method and system for filling gaps | ASM IP私人控股有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119522037-A | Method and system for filling gaps | ASM IP私人控股有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-109985667-B | Device and method for preparing organic phosphine ligand catalyst on line | 内蒙古伊泰煤基新材料研究院有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-116845221-A | Negative electrode material and preparation method thereof, negative electrode, lithium battery and preparation method thereof | 合肥国轩高科动力能源有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-115611822-B | Preparation method of isaconazole intermediate | 四川澄华生物科技有限公司 | 2023-09-19 | — | — | CN | disclosed |
| US-10384942-B2 | Halogen doped phosphorus nanoparticles and manufacturing method thereof | NATIONAL TSING HUA UNIVERSITY (TW) | 2019-08-20 | — | — | US | disclosed |
| CN-109985667-A | The device and method for preparing organophosphine ligand catalyst online | 内蒙古伊泰煤基新材料研究院有限公司 | 2019-07-09 | — | — | CN | disclosed |
| US-8183377-B2 | Process for the preparation of imidazopyridines | ELDER PHARMACEUTICALS LTD. | 2012-05-22 | — | — | US | disclosed |
| CN-1469865-A | Pyrazole derivatives for the treatment of viral diseases | - | 2004-01-21 | — | — | CN | disclosed |
| EP-1341766-A1 | IMIDAZOLONE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 2003-09-10 | — | — | EP | disclosed |
| EP-1326843-A1 | PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES | F. Hoffmann-La Roche AG (CH) | 2003-07-16 | — | — | EP | disclosed |
| US-6518293-B2 | Inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. | HOFFMANN-LA ROCHE INC. | 2003-02-11 | — | — | US | disclosed |
| US-20030018197-A1 | Anti-HIV pyrazole derivatives | HOFFMANN-LA ROCHE INC. | 2003-01-23 | — | — | US | disclosed |
| US-20020107272-A1 | Anti-HIV imidazolone derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2002-08-08 | — | — | US | disclosed |
| WO-2002042279-A1 | IMIDAZOLONE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-05-30 | — | — | WO | disclosed |
| WO-2002030907-A1 | PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-04-18 | — | — | WO | disclosed |
| US-4845085-A | Antifungal agent | MERCK & CO., INC. (US) | 1989-07-04 | — | — | US | disclosed |